NYSE : OWLT
Owlet, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 4.05 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 118.35M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 127.11M |
| Enterprise Value | 113.23M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 29.22M |
| Shares Outstanding | 29.22M |
| Shares Change (YoY) | +69.66% |
| Shares Change (QoQ) | +3.45% |
| Owned by Insiders (%) | 6.76% |
| Owned by Institutions (%) | 39.83% |
| Float | 17.56M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 45.41 |
| PS Ratio | 1.03 |
| Forward PS | 0.92 |
| PB Ratio | 5.04 |
| P/TBV Ratio | 5.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.64 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.84 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.42% |
| Return on Invested Capital (ROIC) | -39.44% |
| Return on Capital Employed (ROCE) | -20.31% |
| Weighted Average Cost of Capital (WACC) | 16.05% |
| Revenue Per Employee | $1.00M |
| Profits Per Employee | -$114,026 |
| Employee Count | 114 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 3.85 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.22 |
| 52-Week Price Change | -58.03% |
| 50-Day Moving Average | 4.75 |
| 200-Day Moving Average | 6.38 |
| Relative Strength Index (RSI) | 34.37 |
| Average Volume (20 Days) | 112,078 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 550,043 |
| Short Previous Month | 549,042 |
| Short % of Shares Out | 1.88% |
| Short % of Float | 3.13% |
| Short Ratio (days to cover) | 3.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 114.41M |
| Gross Profit | 62.44M |
| Operating Income | -8.07M |
| Pretax Income | -9.66M |
| Net Income | -13.00M |
| EBITDA | -7.83M |
| EBIT | -8.07M |
| Loss Per Share | -$0.64 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 30.95M |
| Total Debt | 17.06M |
| Net Cash | 13.89M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 36.83M |
| Book Value Per Share | 0.80 |
| Working Capital | 34.48M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.76M |
| Capital Expenditures | -762,000 |
| Depreciation & Amortization | 244,000 |
| Net Borrowing | -6.33M |
| Free Cash Flow | -8.53M |
| FCF Per Share | -$0.29 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.57% |
| Operating Margin | -7.05% |
| Pretax Margin | -8.44% |
| Profit Margin | -8.44% |
| EBITDA Margin | -6.84% |
| EBIT Margin | -7.05% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -69.66% |
| Shareholder Yield | -69.66% |
| Earnings Yield | -14.69% |
| FCF Yield | -7.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.00 |
| Price Target Difference | 198.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 20.73% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 10, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.97 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |